Clinical Trial Update: Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II trial evaluating weekly cisplatin and irinotecan with radiotherapy in locally advanced esophageal cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasms

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Esophageal Neoplasms | Phase 2 | Status: COMPLETED